SEC Filings

Filing date	Form	Description	View
03/01/24	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0001558370-24-002267.pdf 0001558370-24-002267.rtf 0001558370-24-002267.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
02/28/24	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-24-028809.pdf 0001104659-24-028809.rtf 0001104659-24-028809.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
02/26/24	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-24-027510.pdf 0001104659-24-027510.rtf 0001104659-24-027510.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
02/22/24	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-24-004958.pdf 0001415889-24-004958.rtf 0001415889-24-004958.xls
02/22/24	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-24-004962.pdf 0001415889-24-004962.rtf 0001415889-24-004962.xls
02/22/24	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-24-004960.pdf 0001415889-24-004960.rtf 0001415889-24-004960.xls
02/22/24	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-24-004966.pdf 0001415889-24-004966.rtf 0001415889-24-004966.xls
02/22/24	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-24-004964.pdf 0001415889-24-004964.rtf 0001415889-24-004964.xls
02/22/24	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-24-004968.pdf 0001415889-24-004968.rtf 0001415889-24-004968.xls
02/16/24	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001415889-24-004258.pdf 0001415889-24-004258.rtf 0001415889-24-004258.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.